Merck Animal Health Announces USDA Approval of Innovative Canine Flu Bivalent Vaccine

Dateline City:
MADISON, N.J. First Vaccine to Offer Protection Against Both Strains of Canine InfluenzaMADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United
States and Canada, today announced that the U.S. Department of
Agriculture has approved a license for Nobivac® Canine Flu
Bivalent vaccine – the first vaccine to aid in the control of disease
associated with both canine influenza virus (CIV) H3N2 and canine
influenza virus H3N8.Language:
EnglishContact: MerckMedia:Kelly Goss, [e-mail] Eisele, [e-mail] Relations:Amy Klug, [e-mail] Slug:Ticker:MRKExchange:NYSEread more

Source: Merck.com - Corporate News - October 7, 2016 Category: Pharmaceuticals Tags: Corporate News Animal Health Latest News #Merck #MRK $MRK Merck Animal Health Nobivac NYSE:MRK Source Type: news